scispace - formally typeset
W

Weiwei Wang

Researcher at University of Alberta

Publications -  34
Citations -  1518

Weiwei Wang is an academic researcher from University of Alberta. The author has contributed to research in topics: Breast cancer & Gene. The author has an hindex of 16, co-authored 33 publications receiving 1244 citations. Previous affiliations of Weiwei Wang include Chinese Academy of Sciences & Beijing Institute of Genomics.

Papers
More filters
Journal ArticleDOI

Characterization of the Gut Microbiome Using 16S or Shotgun Metagenomics.

TL;DR: The two main approaches for analyzing the microbiome, 16S ribosomal RNA gene amplicons and shotgun metagenomics, are illustrated with analyses of libraries designed to highlight their strengths and weaknesses and several methods for taxonomic classification of bacterial sequences are discussed.
Journal ArticleDOI

The emission of γ-Ray beams with orbital angular momentum in laser-driven micro-channel plasma target

TL;DR: Three-dimensional particle-in-cell simulations reveal that the spin angular momentum of the CP laser can be transferred to the OAM of accelerated electrons and further to the emitted gamma-ray beam, which may guide future experiments in laser-driven Gamma-ray sources using micro-structures.
Journal ArticleDOI

Proteomic profiling of rice embryos from a hybrid rice cultivar and its parental lines

TL;DR: Most of the differentially expressed genes at both protein and RNA levels are recent gene duplicates (paralogous genes) with relative little difference in protein‐coding regions between orthologous genes (between genes of the two parental genomes) as compared to regulatory regions that harbor numerous indels and base substitutions.
Journal ArticleDOI

Identification of hepatotropic viruses from plasma using deep sequencing: a next generation diagnostic tool.

TL;DR: An unbiased metagenomics survey using plasma from patients with chronic hepatitis B, chronic hepatitis C, autoimmune hepatitis (AIH), non-alcoholic steatohepatitis (NASH), and patients without liver disease established a reliable protocol for the identification of viruses in plasma that can also be adapted to other patient samples such as urine, bile, saliva and other body fluids.